Skip to main content
. Author manuscript; available in PMC: 2012 Apr 27.
Published in final edited form as: Support Care Cancer. 2010 May 25;19(6):833–841. doi: 10.1007/s00520-010-0911-0

Table 4. Maximum adverse events by arm related to central nervous system depression.

BAK (N=101) Placebo (N=102)
Confusion
 None 95 (95%) 97 (97%)
 Mild (1) 5 (5%) 2 (2%)
 Severe (3) 0 1 (1%)
Low consciousness
 None 98 (98%) 98 (98%)
 Moderate 1 (1%) 2 (2%)
 Severe 1 (1%) 0 (%)
Constipation
 None 76 (76%) 74 (74%)
 Mild 18 (18%) 22 (22%)
 Moderate 5 (5%) 4 (4%)
 Severe 1 (1%) 0 (0%)
Rash
 None 84 (84%) 90 (90%)
 Mild 11 (11%) 6 (6%)
 Moderate 5 (5%) 4 (4%)
Dry mouth
 None 83 (83%) 78 (78%)
 Mild 17 (17%) 22 (22%)